Dr. Lesser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1991 - 1994
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1987 - 1991
- Pennsylvania State University College of MedicineClass of 1987
Certifications & Licensure
- NC State Medical License 1995 - 2025
- VA State Medical License 1994 - 2012
- MD State Medical License 1991 - 1996
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2024
- America's Top Doctors for Cancer Castle Connolly, 2005-2021
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013
Clinical Trials
- Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme Start of enrollment: 2000 May 01
- Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer Start of enrollment: 2004 Mar 01
- Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Effectiveness of a Cardiovascular Health Electronic Health Record Application for Cancer Survivors in Community Oncology Practice: Results From WF-1804CD.Kathryn E Weaver, Emily V Dressler, Heidi D Klepin, Simon C Lee, Brian J Wells
Journal of Clinical Oncology. 2024-11-21 - The National Cancer Institute Clinical Trials Planning Meeting to Address Gaps in Observational and Intervention Trials for Cancer-Related Cognitive Impairment.Michelle C Janelsins, Kathleen Van Dyk, Sheri J Hartman, Thuy T Koll, Christina K Cramer
Journal of the National Cancer Institute. 2024-09-09 - Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT.Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng
Clinical Cancer Research. 2024-08-01
Press Mentions
- Study: Donepezil Does Not Improve Chemotherapy-Related Cognitive Impairment for Breast Cancer SurvivorsMay 20th, 2024
- Cancer Researchers at Wake Forest Baptist Receive $25 Million from National Cancer InstituteSeptember 23rd, 2019
- What Are the Symptoms of Glioblastoma? Brain Cancer Treatment, Survival RatesJuly 17th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: